首页> 外文期刊>Southern Medical Journal >Sex-specific substance abuse treatment for female healthcare professionals: Implications
【24h】

Sex-specific substance abuse treatment for female healthcare professionals: Implications

机译:女性保健专业人员的按性别分类的药物滥用治疗:含义

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVES: Gender plays a significant role in the development and treatment of substance abuse disorders. Sex-specific treatment for girls and women has recurrently proven more effective, with better outcomes than traditional treatment. Research on impaired healthcare professionals (HCPs) has largely focused on men, garnering little attention for women and sex differences. With the increasing numbers of female HCPs, it is imperative to identify potential sex differences that may have implications for treatment. Our study compared a convenience sample of male and female HCPs with substance abuse disorders treated in an outpatient program to identify sex differences that may have implications for treatment. METHODS: Our sample consisted of 96 HCPs (54 men, 42 women) and 17 non-healthcare professional (N-HCP) women. All of the participants were evaluated using the program's clinical interview and the Personality Assessment Inventory (PAI). Chart review data contained categorical variables, qualitative variables, diagnoses, and psychological test scores. A second analysis was conducted through two separate comparisons: the PAI results of comparing impaired female HCPs with impaired male HCPs and the PAI results of comparing impaired female HCPs with impaired female N-HCPs. RESULTS: Statistically significant differences indicated more male participants received prior treatment and more intensive treatment than female participants. More female subjects reported being diagnosed as having a comorbid psychiatric condition and taking psychotropic medications. Several statistically significant differences in the PAI scores were found. Among female HCPs, elevations were found in anxiety, depression, paranoia, and borderline personality disorder. Substantive differences, although not statistically significant, were elevations in somatic complaints and anxiety disorders in female HCPs. In the comparison of female HCPs and N-HCPs, the only statistically significant difference was the significantly higher anxiety score of N-HCPs. CONCLUSIONS: The results indicate greater differences between female HCPs and male HCPs than between female HCPs and N-HCPs.
机译:目标:性别在药物滥用疾病的发生和治疗中起着重要作用。事实证明,针对女孩和妇女的针对性别的治疗比传统治疗更有效,而且效果更好。对受损的医疗保健专业人员(HCP)的研究主要集中于男性,对女性和性别差异的关注很少。随着女性HCP数量的增加,必须确定可能对治疗产生影响的潜在性别差异。我们的研究比较了在门诊程序中治疗的男性和女性HCP与药物滥用障碍的便利性样本,以确定可能对治疗产生影响的性别差异。方法:我们的样本包括96名HCP(54名男性,42名女性)和17名非医疗保健专业人员(N-HCP)妇女。使用该计划的临床访谈和人格评估清单(PAI)对所有参与者进行了评估。图表审查数据包含分类变量,定性变量,诊断和心理测验分数。通过两个单独的比较进行第二次分析:将受损的女性HCP与受损的男性HCP进行比较的PAI结果,以及将受损的女性HCP与受损的女性N-HCP进行比较的PAI结果。结果:统计学上的显着差异表明,与女性相比,接受过先前治疗和强化治疗的男性参与者更多。据报告,有更多的女性受试者被诊断患有精神病合并症并服用了精神药物。在PAI评分中发现了几个具有统计学意义的差异。在女性HCP中,发现焦虑,抑郁,偏执狂和边缘性人格障碍升高。实质性差异(尽管无统计学意义)是女性HCP的躯体主诉和焦虑症升高。在女性HCP和N-HCP的比较中,唯一具有统计学意义的差异是N-HCP的焦虑评分明显更高。结论:结果表明,女性HCP和男性HCP之间的差异大于女性HCP和N-HCP之间的差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号